ISAVRAD Project AFRICA

The Chronic Neuropsychiatric Sequelae of SARS-Cov-2 (ISAVRAD Project) is to explore the impact of COVID-19 on brain health, alongside the well-being of individuals who haven’t had the virus. This project aims to provide new insights into how our minds and bodies have been affected by the pandemic, focusing on brain activity, genetic factors, and cognitive health.

Research Goals

  • Understand Long-Term Brain Health: Examine the lasting effects of COVID-19 on the brain and mental health.
  • Assess Genetic Influences: Identify how genetics and environmental factors contribute to brain health in different populations.
  • Promote Healthy Aging: Discover ways to support long-term cognitive health and quality of life in diverse communities.

What We Offer

Brain and Mental Health Assessments

Genetic and Biomarker Testing

MRI Brain Imaging

Long-Term Health Follow-Up

Educational Resources and Community Support

Participation in Global Research

Why Participate?

By joining our study, you’ll be part of a global initiative to improve brain health outcomes. Your involvement can help us make vital discoveries that benefit our communities and future generations. Participants will receive regular updates on their health and contribute to a deeper understanding of brain health.

Who Can Join?

We welcome individuals aged 60 and above, whether or not they have had COVID-19. Participation is open to those with no history of major neurological or psychiatric conditions.

How to Get Involved

If you’re interested in contributing to this groundbreaking research, please contact us to learn more about eligibility and how you can participate.

Privacy and Confidentiality

We are committed to protecting the privacy of all participants. All data collected will be securely stored and used only for research purposes.

Lead Investigators

Prof. Rufus Olusola Akinyemi, MD, PhD, FAS

Professor of Geriatric Neurology and Translational Neuroscience, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Nigeria.

Gabriel A. de Erausquin, MD, PhD